10-QFiling Date: May 6, 2026

Edwards Lifesciences (EW) 10-Q (May 6, 2026)

ew-20260331

View SEC Filing

ACC: 0001099800-26-000026

Key Financial Metrics3M Mar'26 · 2026-03-31

Revenue$1.65B

Net Income$380.7M

Total Assets$13.32B

Stockholders' Equity$14.62B

Operating Cash Flow$43.8M

More filings from Edwards Lifesciences (EW)

Recent 10-Q filings from other companies

PepsiCo 10-Q · Oct 8, 2026Quarterly Report · ended 2026-09-05 · Rev $25.3B, NI $3.0B
Cintas (CTAS) 10-Q · Oct 7, 2026Quarterly Report · ended 2026-08-31 · Rev $3.0B, NI $551.7M
Constellation Brands (STZ) 10-Q · Oct 7, 2026Quarterly Report · ended 2026-08-31 · Rev $5.4B, NI $1.2B
Lennar 10-Q · Oct 2, 2026Quarterly Report · ended 2026-08-31 · Rev $8.0B, NI $283.9M
Nike (NKE) 10-Q · Oct 2, 2026Quarterly Report · ended 2026-08-31 · Rev $11.2B, NI $712.0M